240
Participants
Start Date
July 31, 2004
Study Completion Date
September 30, 2006
Efavirenz + 2 NRTIs
Lopinavir/Ritonavir + 2 NRTIs
Therapeutic Drug Monitoring
Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx
SUNY Stony Brook NICHD CRS, Stony Brook
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore
St. Jude/UTHSC CRS, Memphis
Chicago Children's CRS, Chicago
Tulane/LSU Maternal/Child CRS, New Orleans
Children's Hosp., New Orleans
Children's Med. Ctr. Dallas, Dallas
Texas Children's Hosp. CRS, Houston
Univ. of Colorado Denver NICHD CRS, Aurora
Children's Hospital of Los Angeles NICHD CRS, Los Angeles
Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach
Usc La Nichd Crs, Alhambra
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH